Evidence map›Paper›PMID 27717402›Full record

ArticleMalaria journal2016

Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation.

Mary Prahl, Prasanna Jagannathan, Tara I McIntyre, Ann Auma, Lila Farrington, Samuel Wamala, Mayimuna Nalubega, Kenneth Musinguzi, Kate Naluwu, Esther Sikyoma and 10 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02282293 (Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02282293 phase3completednot on this map

Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE Birth Cohort 2)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2014 to 2016Enrolled200ConditionsMalaria, Human Immunodeficiency VirusArmsMonthly dihydroartemisinin-piperaquine (DP) + daily trimethoprim/sulfamethoxazole (TS), Monthly placebo + daily trimethoprim/sulfamethoxazole (TS)
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. The immune response to malaria in utero.Immunological reviews · 2020
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Management of malaria in pregnancy.The Indian journal of medical research · 2017
    Review
  18. Sex Disparity in Cord Blood FoxP3Open forum infectious diseases · 2017
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Mary PrahlDepartment of Pediatrics, University of California-San Francisco, 3333 California Street, Suite 315, Box 1234, San Francisco, CA, 94143, USA.ORCID 0000-0003-0091-2731
Prasanna JagannathanDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Tara I McIntyreDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Ann AumaInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Lila FarringtonDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Samuel WamalaInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Mayimuna NalubegaInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Kenneth MusinguziInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Kate NaluwuInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Esther SikyomaInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Rachel BudkerDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Hilary VanceDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Pamela OdorizziDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Patience NayebareInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
John AtegekaInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Abel KakuruInfectious Diseases Research Collaboration, 2C Nakasero Hill Road, PO Box 7475, Kampala, Uganda.
Diane V HavlirDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Moses R KamyaSchool of Medicine, College of Health Sciences, Makerere University of College of Health Sciences, PO Box 7072, Kampala, Uganda.
Grant DorseyDepartment of Medicine, University of California-San Francisco, 3333 California Street, Suite 315, San Francisco, CA, 94143, USA.
Margaret E FeeneyDepartment of Pediatrics, University of California-San Francisco, 3333 California Street, Suite 315, Box 1234, San Francisco, CA, 94143, USA. Margaret.feeney@ucsf.edu.
University of California, San Francisco · USInfectious Diseases Research Collaboration · UGMakerere University · UG

Funding

San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
The immunologic consequences of prenatal exposure to malariaP01HD059454 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2008 to 2017
$22.6M
The role of γδ T cells in fetal and infant immune defense against malariaR01AI093615 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2011 to 2025
$9.1M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
Mentoring Translational Researchers for Careers in Pediatric Global HealthK24AI113002 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2014 to 2023
$1.9M
The Immunologic Impact of In Utero Malaria Exposure and Prenatal ChemopreventionK23AI127886 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRAHL, MARY · 2017 to 2021
$1.0M
Immunologic Consequences of Highly Effective Antimalarial ChemopreventionK23AI100949 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANNATHAN, PRASANNA · 2012 to 2016
$657k
NIAID NIH HHS K23 AI100949NIAID NIH HHS K23 AI127886NIAID NIH HHS K24 AI113002NIAID NIH HHS R01 AI093615NIAID NIH HHS T32 AI060530NIAID NIH HHS UM1 AI069496NICHD NIH HHS P01 HD059454
6 · The paper itself

Abstract

backgroundIn malaria-endemic areas, the first exposure to malaria antigens often occurs in utero when the fetal immune system is poised towards the development of tolerance. Children exposed to placental malaria have an increased risk of clinical malaria in the first few years of life compared to unexposed children. Recent work has suggested the potential of pregnancy-associated malaria to induce immune tolerance in children living in malaria-endemic areas. A study was completed to evaluate the effect of malaria exposure during pregnancy on fetal immune tolerance and effector responses.

methodsUsing cord blood samples from a cohort of mother-infant pairs followed from early in pregnancy until delivery, flow cytometry analysis was completed to assess the relationship between pregnancy-associated malaria and fetal cord blood CD4 and dendritic cell phenotypes.

resultsCord blood FoxP3

conclusionTogether, these data indicate that in utero exposure to malaria drives expansion of both regulatory and effector T cells in the fetus, and that the timing of this exposure has a pivotal role in determining the polarization of the fetal immune response.

Indexed as

CD4-Positive T-LymphocytesCohort StudiesDendritic CellsFemaleFetal BloodFlow CytometryHumansImmunophenotypingInfant, NewbornMalariaPlacenta DiseasesPlasmodiumPregnancyPregnancy Complications, InfectiousYoung AdultCD4 T cellsDendritic cellsFetal immune responseImmune toleranceLoop-mediated isothermal amplificationPregnancy-associated malaria

Identifiers

PMID27717402
PMCPMC5055709
OpenAlexW2527991213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.